Publications

Export 365 results:
Sort by: [ Author  (Asc)] Title Type Year
A B C D E F G H I J K L M N O [P] Q R S T U V W X Y Z   [Show ALL]
P
Periyasamy, S., V. Karthik, P. Senthil Kumar, B. J. Isabel, T. Temesgen, B. M. Hunegnaw, B. B. Melese, B. A. Mohamed, and D. - V. N. Vo, Chemical, physical and biological methods to convert lignocellulosic waste into value-added products. A review, , vol. 20, issue 2, pp. 1129 - 1152, 2022. AbstractWebsite

Actual agricultural practices produce about 998 million tonnes of agricultural waste per year. Therefore, converting lignocellulosic wastes into energy, chemicals, and other products is a major goal for the future circular economy. The major challenge of lignocellulosic biorefineries is to transform individual components of lignocellulosic biomass into valuable products. Here we review lignocellulosic biomasses such as coffee husk, wheat straw, rice straw, corn cob, and banana pseudostem. We present pretreatment technologies such as milling, microwave irradiation, acidic, alkaline, ionic liquid, organosolv, ozonolysis, steam explosion, ammonia fiber explosion, and CO2 explosion methods. These methods convert biomass into monomers and polymers. For that, the concoction pretreatment methods appear promising.

Perros, H. G., and K. M. Elsayed, "Call admission control schemes: a review", IEEE Communications Magazine, vol. 34, no. 11, pp. 82–91, 1996. Abstract
n/a
Perveen, S., G. A. Fawzy, and A. A. Taweel, "Hepatoprotective and cytotoxic activities of Anvillea garcinii and isolation of four new secondary metabolites", Journal of Natural Medicines, vol. 72, pp. 106-117, 2018. j_nat_med_10.1007_s11418-017-1118-1.pdf
Perveen, S., G. A. Fawzy, and A. A. Taweel, "Antiulcer Activity of Different Extracts of Anvillea garcinii and Isolation of Two New Secondary Metabolites", Open Chemistry, vol. 16, pp. 437-445, 2018. paper_no_8.pdf
Pesa, A. M., and N. E. Fekry, "BACHELOR NURSES' PERCEPTION OF THE BARRIERS AND FACILITATORS FOR IMPLEMENTING EVIDENCE-BASED NURSING PRACTICE", The 12th International Scientific Nursing Conference, Alex, 15/5/2013. full_paper.pdf
Pesa, M. A., and N. E. - D. Fekry, "Key Predictors of Attraction and Retention of Nurses at Workplace", IMPACT: International Journal of Research in Applied, , vol. 5, issue 6, pp. 1-14, 2017.
Pessa, J., R. Riefkohl, and W. J. Burwick, "Principles of cartilage grafting", Textbook of plastic, maxillofacial and reconstructive surgery: Williams and Wilkins, Baltimore, pp. 79-81, 1992. Abstract
n/a
Pessa, M. A., and N. E. - D. Fikry,  Bacholar nurses' perception of the barriers and facilitators for implementing Evidence-Based Nursing Practice, , Germany, LAP Lambert Academic Publishing, 2014.
Peter, N., S. Bandyopadhyay, and K. Lakhoo, "Impact of the COVID-19 pandemic on paediatric patients with cancer in low-income, middle-income and high-income countries: protocol for a multicentre, international, observational cohort study", BMJ Open, vol. 11, no. 6: British Medical Journal Publishing Group, 2021. AbstractWebsite

Introduction Childhood cancers are a leading cause of non-communicable disease deaths for children around the world. The COVID-19 pandemic may have impacted on global children’s cancer services, which can have consequences for childhood cancer outcomes. The Global Health Research Group on Children’s Non-Communicable Diseases is currently undertaking the first international cohort study to determine the variation in paediatric cancer management during the COVID-19 pandemic, and the short-term to medium-term impacts on childhood cancer outcomes.Methods and analysis This is a multicentre, international cohort study that will use routinely collected hospital data in a deidentified and anonymised form. Patients will be recruited consecutively into the study, with a 12-month follow-up period. Patients will be included if they are below the age of 18 years and undergoing anticancer treatment for the following cancers: acute lymphoblastic leukaemia, Burkitt lymphoma, Hodgkin lymphoma, Wilms tumour, sarcoma, retinoblastoma, gliomas, medulloblastomas and neuroblastomas. Patients must be newly presented or must be undergoing active anticancer treatment from 12 March 2020 to 12 December 2020. The primary objective of the study was to determine all-cause mortality rates of 30 days, 90 days and 12 months. This study will examine the factors that influenced these outcomes. χ2 analysis will be used to compare mortality between low-income and middle-income countries and high-income countries. Multilevel, multivariable logistic regression analysis will be undertaken to identify patient-level and hospital-level factors affecting outcomes with adjustment for confounding factors.Ethics and dissemination At the host centre, this study was deemed to be exempt from ethical committee approval due to the use of anonymised registry data. At other centres, participating collaborators have gained local approvals in accordance with their institutional ethical regulations. Collaborators will be encouraged to present the results locally, nationally and internationally. The results will be submitted for publication in a peer-reviewed journal.

Peter, E. B., and S. M. Metwalli, Interactive computer aided design and animation of spatial mechanisms, : University of Central Florida, Orlando, 1983. Abstract
n/a
Peters, J. F., and S. K. Pal, "Cantor, fuzzy, near, and rough sets in image analysis", Rough fuzzy image analysis: Foundations and methodologies: CRC Press, pp. 1–1, 2010. Abstract
n/a
Peterson, P. M., H. A.Hosni, and E. K. Shamso, "A key to the grasses (Poaceae) of Egypt", Webbia. Journal of Plant Taxonomy and Geography , vol. 75, issue 2, pp. 329-353, 2020. a_key_to_the_grasses.pdf
Peterson, G. S., M. A. Kandil, M. D. Abdallah, and A. ‐aalA. Farag, "Isolation and characterisation of biologically‐active compounds from some plant extracts", Pest Management Science, vol. 25, issue 4: Wiley Online Library, pp. 337-342, 1989. Abstract
n/a
Peterson, P. M., H. A.Hosni, and E. M. Shamso, "A key to the grasses (Poaceae) of Egypt", Webbia, vol. 75, issue 2, pp. 329-353, 2020. a_key_to_the_grasses_of_egypt.pdf
Peth, J. - Y., M. Rietjens, O. Youssef, and F. De Lorenzi, "Pedicled TRAM flap reconstruction", Oncoplastic and Reconstructive Surgery of the Breast: Taylor & Francis, pp. 75, 2004. Abstract
n/a
Petit, J. Y., M. Rietjens, F. De Lorenzi, and O. Youssef, Transversus abdominis myocutaneous pedicled flap, , Submitted. Abstract
n/a
Petit, J. Y., U. Veronesi, R. Orecchia, P. Rey, S. Martella, F. Didier, G. Viale, P. Veronesi, A. Luini, V. Galimberti, et al., "Nipple sparing mastectomy with nipple areola intraoperative radiotherapy: one thousand and one cases of a five years experience at the European institute of oncology of Milan (EIO)", Breast cancer research and treatment, vol. 117, no. 2: Springer, pp. 333–338, 2009. Abstract
n/a
Petit, J. - Y., M. Rietjens, O. Youssef, and F. De Lorenzi, "Pedicled TRAM flap reconstruction", Oncoplastic and Reconstructive Surgery of the Breast: Taylor & Francis, pp. 77, 2004. Abstract
n/a
Petit, J., O. Youssef, M. Rjetjens, M. D'Ambrosio, A. Luini, S. Massaron, A. Vanazzi, and G. Martinelli, "Should breast reconstruction be delayed in high-risk breast cancer patients (pts) receiving High-Dose Chemotherapy (HDC)?", BONE MARROW TRANSPLANTATION, vol. 27: NATURE PUBLISHING GROUP HOUNDMILLS, BASINGSTOKE RG21 6XS, HAMPSHIRE, ENGLAND, pp. S119–S119, 2001. Abstract
n/a
Petit, J. Y., C. Garusi, M. Greuse, M. Rietiens, O. Youssef, A. Luini, and F. De Lorenzi, "One hundred and eleven cases of breast conservation treatment with simultaneous reconstruction at the European Institute of Oncology (Milan).", Tumori, vol. 88, no. 1, pp. 41–47, 2001. Abstract
n/a
Petit, J. - Y., O. Youssef, and C. Garusi, "10 Breast reconstruction after conservative surgery", Oncoplastic and Reconstructive Surgery of the Breast: Taylor & Francis, pp. 101, 2004. Abstract
n/a
Petit, J. Y., M. Rietjens, C. Garusi, A. Giraldo, F. De Lorenzi, P. Rey, E. C. Millen, B. P. da Silva, R. Bosco, and O. Youssef, "Abdominal complications and sequelae after breast reconstruction with pedicled TRAM flap: is there still an indication for pedicled TRAM in the year 2003?", Plastic and reconstructive surgery, vol. 112, no. 4: LWW, pp. 1063–1065, 2003. Abstract
n/a
Pettigrew, A. M., Contextualist {Research} and the {Study} of {Organizational} {Change} {Processes}, : North-Holland, pp. 53–78, 1985. Abstract

meanings are not discovered but created by a process of making

Peyvandi, F., P. M. Mannucci, I. Garagiola, A. El-Beshlawy, M. Elalfy, V. Ramanan, P. Eshghi, S. Hanagavadi, R. Varadarajan, M. Karimi, et al., "A Randomized Trial of Factor VIII and Neutralizing Antibodies in Hemophilia A.", The New England journal of medicine, vol. 374, issue 21, pp. 2054-64, 2016 May 26. Abstract

BACKGROUND: The development of neutralizing anti-factor VIII alloantibodies (inhibitors) in patients with severe hemophilia A may depend on the concentrate used for replacement therapy.

METHODS: We conducted a randomized trial to assess the incidence of factor VIII inhibitors among patients treated with plasma-derived factor VIII containing von Willebrand factor or recombinant factor VIII. Patients who met the eligibility criteria (male sex, age <6 years, severe hemophilia A, and no previous treatment with any factor VIII concentrate or only minimal treatment with blood components) were included from 42 sites.

RESULTS: Of 303 patients screened, 264 underwent randomization and 251 were analyzed. Inhibitors developed in 76 patients, 50 of whom had high-titer inhibitors (≥5 Bethesda units). Inhibitors developed in 29 of the 125 patients treated with plasma-derived factor VIII (20 patients had high-titer inhibitors) and in 47 of the 126 patients treated with recombinant factor VIII (30 patients had high-titer inhibitors). The cumulative incidence of all inhibitors was 26.8% (95% confidence interval [CI], 18.4 to 35.2) with plasma-derived factor VIII and 44.5% (95% CI, 34.7 to 54.3) with recombinant factor VIII; the cumulative incidence of high-titer inhibitors was 18.6% (95% CI, 11.2 to 26.0) and 28.4% (95% CI, 19.6 to 37.2), respectively. In Cox regression models for the primary end point of all inhibitors, recombinant factor VIII was associated with an 87% higher incidence than plasma-derived factor VIII (hazard ratio, 1.87; 95% CI, 1.17 to 2.96). This association did not change in multivariable analysis. For high-titer inhibitors, the hazard ratio was 1.69 (95% CI, 0.96 to 2.98). When the analysis was restricted to recombinant factor VIII products other than second-generation full-length recombinant factor VIII, effect estimates remained similar for all inhibitors (hazard ratio, 1.98; 95% CI, 0.99 to 3.97) and high-titer inhibitors (hazard ratio, 2.59; 95% CI, 1.11 to 6.00).

CONCLUSIONS: Patients treated with plasma-derived factor VIII containing von Willebrand factor had a lower incidence of inhibitors than those treated with recombinant factor VIII. (Funded by the Angelo Bianchi Bonomi Foundation and others; ClinicalTrials.gov number, NCT01064284; EudraCT number, 2009-011186-88.).